Browse "Dept. of Chemistry(화학과)" by Author Son, Mi Kwon
Showing results 1 to 13 of 13
| A novel imidazopyridine derivative, HS-106, induces apoptosis of breast cancer cells and represses angiogenesis by targeting the PI3K/mTOR pathway Li, Guang-Yong; Jung, Kyung Hee; Lee, Hyunseung; Son, Mi Kwon; Seo, JuHyeon; Hong, Sang-Won; Jeong, Yujeong; et al, CANCER LETTERS, v.329, no.1, pp.59 - 67, 2013-02 |
| A novel imidazopyridine PI3K inhibitor with anticancer activity in non-small cell lung cancer cells Lee, Hyunseung; Kim, Soo Jung; Jung, Kyung Hee; Son, Mi Kwon; Yan, Hong Hua; Hong, Sungwoo; Hong, Soon-Sun, ONCOLOGY REPORTS, v.30, no.2, pp.863 - 869, 2013-08 |
| A novel PI3K inhibitor alleviates fibrotic responses in fibroblasts derived from Peyronie's plaques Jung, Kyung Hee; Ryu, Ye-Lim; Lee, Hee-Seung; Lee, Hyunseung; Son, Mi Kwon; Yan, Hong Hua; Hong, Sang-Won; et al, INTERNATIONAL JOURNAL OF ONCOLOGY, v.42, no.6, pp.2001 - 2008, 2013-06 |
| Anti-cancer effect of HS-345, a new tropomyosin-related kinase A inhibitor, on human pancreatic cancer Seo, Ju Hyeon; Jung, Kyung Hee; Son, Mi Kwon; Yan, Hong Hua; Ryu, Ye-Lim; Kim, Jinhee; Lee, Jung Kyun; et al, CANCER LETTERS, v.338, no.2, pp.271 - 281, 2013-09 |
| Anticancer activity of HS-527, a novel inhibitor targeting PI3-kinase in human pancreatic cancer cells Ryu, Ye-Lim; Jung, Kyung Hee; Son, Mi Kwon; Yan, Hong Hua; Kim, Soo Jung; Shin, Sang Hye; Hong, Sungwoo; et al, CANCER LETTERS, v.353, no.1, pp.68 - 77, 2014-10 |
| HS-104, a PI3K inhibitor, enhances the anticancer efficacy of gemcitabine in pancreatic cancer Jung, Kyung Hee; Yan, Hong Hua; Fang, Zhenghuan; Son, Mi Kwon; Lee, Hyunseung; Hong, Sungwoo; Hong, Soon-Sun, INTERNATIONAL JOURNAL OF ONCOLOGY, v.45, no.1, pp.311 - 321, 2014-07 |
HS-133, a novel fluorescent phosphatidylinositol 3-kinase inhibitor as a potential imaging and anticancer agent for targeted therapy Lee, Ju-Hee; Jung, Kyung Hee; Lee, Hyunseung; Son, Mi Kwon; Yun, Sun-Mi; Ahn, Sung-Hoon; Lee, Kyeong-Ryoon; et al, ONCOTARGET, v.5, no.20, pp.10180 - 10197, 2014-10 |
| HS-173, a novel PI3K inhibitor suppresses EMT and metastasis in pancreatic cancer Rumman, Marufa; Jung, Kyung Hee; Fang, Zhenghuan; Yan, Hong Hua; Son, Mi Kwon; Kim, Soo Jung; Kim, Juyoung; et al, ONCOTARGET, v.7, no.47, pp.78029 - 78047, 2016-11 |
| HS-173, a Novel PI3K Inhibitor, Attenuates the Activation of Hepatic Stellate Cells in Liver Fibrosis Son, Mi Kwon; Ryu, Ye-Lim; Jung, Kyung Hee; Lee, Hyunseung; Lee, Hee Seung; Yan, Hong Hua; Park, Heon Joo; et al, SCIENTIFIC REPORTS, v.3, 2013-12 |
| HS-438, a new inhibitor of Imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemia Yun, Sun-Mi; Jung, Kyung Hee; Kim, Soo Jung; Fang, Zhenghuan; Son, Mi Kwon; Yan, Hong Hua; Lee, Hyunseung; et al, CANCER LETTERS, v.348, no.1-2, pp.50 - 60, 2014-06 |
| HS-543 induces apoptosis of Imatinib-resistant chronic myelogenous leukemia with T315I mutation Kim, Soo Jung; Jung, Kyung Hee; Yan, Hong Hua; Son, Mi Kwon; Fang, Z; Ryu, Ye-Lim; Lee, Hyunseung; et al, ONCOTARGET, v.6, no.3, pp.1507 - 1518, 2015-01 |
| Suppression of tumor proliferation and angiogenesis of hepatocellular carcinoma by HS-104, a novel phosphoinositide 3-kinase inhibitor Jung, Kyung Hee; Zheng, Hong-Mei; Jeong, Yujeong; Choi, Myung-Joo; Lee, Hyunseung; Hong, Sang-Won; Lee, Hee-Seung; et al, CANCER LETTERS, v.328, no.1, pp.176 - 187, 2013-01 |
| Synergistic anticancer activity of HS-173, a novel PI3K inhibitor in combination with Sorafenib against pancreatic cancer cells Yun, Sun-Mi; Jung, Kyung Hee; Lee, Hyunseung; Son, Mi Kwon; Seo, Ju-Hyeon; Yan, Hong Hua; Park, Byung Hee; et al, CANCER LETTERS, v.331, no.2, pp.250 - 261, 2013-05 |
Discover
Type
- 5,814 Article
- 2,286 Conference
- 436 Patent
- 1,195 Thesis(Master)
- 1,052 Thesis(Ph.D)
Open Access
- 303 OA Article
Date issued
- 1,440 2020 - 2024
- 3,826 2010 - 2019
- 2,636 2000 - 2009
- 1,794 1990 - 1999
- 781 1980 - 1989